JavaScript is disabled in your browser. For the best experience, please enable it. All essential information and navigation links remain available below.

Sign in

Homepage
Medications
Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union

Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union

Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union

1 / 1

241 views

Download

Pharmaceutical

Public statement on Ivabradine JensonR: Withdrawal of the marketing authorisation in the European Union

Advanced pharmaceutical formulation for targeted therapeutic intervention.

Dosage

-

Strength

-

Pack Size

-

Form

-

Source

European Medicines Agency

View Source

Related Clinical Articles

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

Clinical Research

View All Alternatives

Related Medications

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

Generic Class

View All Alternatives